Are These Healthcare Stocks Top Takeover Targets?
Following Gilead Sciences' (NASDAQ: GILD) decision to buy Kite Pharma (NASDAQ: KITE) for $11.9 billion in cash, we couldn't help but wonder what other healthcare stocks could be takeover targets, too.
In this episode of The Motley Fool's Industry Focus Healthcare podcast, contributor Todd Campbell joins host Kristine Harjes to discuss how Juno Therapeutics' (NASDAQ: JUNO) pursuit of a safer CAR-T cancer drug could make it a merger and acquisition target and how Mazor Robotics' (NASDAQ: MZOR) robots are disrupting spine surgery and catching Medtronic's (NYSE: MDT) eye in the process.
A full transcript follows the video.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€17.00
-0.580%
Teva Pharmaceutical Industries Ltd ADR is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
As a result the target price of 19 € shows a slightly positive potential of 11.76% compared to the current price of 17.0 € for Teva Pharmaceutical Industries Ltd ADR.
